Veozah (fezolinetant): Uses, Side Effects, Interactions, Pictures, Warnings & Dosing

Note: This article is for educational publishing purposes only. Veozah is a prescription medicine, and dosing or treatment decisions should always be made by a licensed healthcare professional.

Hot flashes have a flair for drama. They show up during meetings, while you are trying to sleep, in grocery store checkout lines, and sometimes for no reason other than your internal thermostat apparently hired a prankster. For many adults going through menopause, these sudden waves of heat and night sweats are more than annoying; they can interrupt sleep, focus, mood, confidence, and daily comfort.

Veozah, the brand name for fezolinetant, is a prescription, nonhormonal medication approved in the United States to reduce moderate to severe vasomotor symptoms due to menopause. In plain English, it is used for menopause-related hot flashes and night sweats. Unlike estrogen therapy, Veozah does not replace hormones. Instead, it works in the brain’s temperature-control system, where hot flashes often get their marching orders.

Because Veozah also carries an important liver warning, it is not a “grab it and go” medication. It requires blood tests before treatment and during treatment. That may sound about as exciting as reading printer instructions, but it matters. This guide explains what Veozah is used for, how it works, its common and serious side effects, drug interactions, tablet appearance, warnings, and labeled dosing basics.

Quick Facts About Veozah

What Is Veozah?

Veozah is a prescription tablet containing fezolinetant. It is designed for adults with moderate to severe vasomotor symptoms caused by menopause. Vasomotor symptoms are the medical term for hot flashes and night sweats, which happen when the body’s heat-regulation system becomes more reactive during the menopause transition.

The big headline is that Veozah is nonhormonal. That makes it different from menopausal hormone therapy, which uses estrogen alone or estrogen plus a progestogen depending on the patient’s health history. Hormone therapy remains an effective option for many people, but it is not appropriate for everyone. Some patients may be advised to avoid hormones because of certain medical histories or risk factors. Veozah gives clinicians another option to discuss.

That said, “nonhormonal” does not mean “risk-free.” A seatbelt is not a parachute, and a prescription label is not decorative wallpaper. Veozah has specific safety requirements, especially around liver monitoring and drug interactions.

Veozah Uses: What Is It Prescribed For?

Veozah is approved to reduce moderate to severe hot flashes and night sweats due to menopause. These symptoms can vary from mildly inconvenient to deeply disruptive. A mild hot flash may feel like a quick warm wave. A severe one can soak clothing, interrupt sleep, trigger embarrassment, and make a person feel as though someone secretly installed a tiny furnace under the rib cage.

Veozah is not approved for every possible cause of sweating, flushing, or sudden heat sensations. Hot flashes can also be related to thyroid problems, infections, anxiety, medications, cancer treatments, and other health conditions. That is why diagnosis matters. If symptoms are new, unusual, severe, or paired with chest pain, fainting, unexplained weight loss, fever, or shortness of breath, medical evaluation is important.

How Veozah Works

Veozah blocks neurokinin 3 receptors, often shortened to NK3 receptors. These receptors are involved in signaling pathways that help regulate body temperature. During menopause, estrogen levels decline, and this can affect temperature-control neurons in the brain. The result may be a narrower “comfort zone,” meaning the body may react dramatically to small temperature changes.

Think of the brain’s thermostat like a smart home device that suddenly gets overly sensitive. Instead of calmly adjusting the air conditioning, it hits the panic button, opens all the windows, and yells, “We are overheating!” Veozah helps reduce that overactive signaling by blocking NK3 receptor activity. The goal is fewer and less intense hot flashes, not a total rewrite of biology’s operating system.

Veozah Dosing Basics

The labeled Veozah dose is one 45 mg tablet taken by mouth once daily, with or without food, when prescribed by a healthcare professional. It is generally taken at about the same time each day. The tablet should be swallowed whole with liquid and should not be cut, crushed, or chewed.

If a dose is missed, the patient information advises taking it as soon as possible on the same day if there are at least 12 hours before the next scheduled dose. If there are fewer than 12 hours before the next dose, the missed dose is skipped and the regular schedule resumes the next day. A double dose should not be taken to “catch up.” Medication math is not the place to get creative.

Before starting Veozah, healthcare providers should order liver blood tests. Follow-up liver testing is recommended monthly for the first three months, then again at month six and month nine after starting treatment, or sooner if symptoms suggest liver problems. These lab checks are a central part of safe use.

What Does Veozah Look Like? Tablet Pictures and Identification

Official labeling describes Veozah 45 mg tablets as round, light red, film-coated tablets. They are debossed with the Astellas logo and “645” on the same side. Online pill pictures can be helpful, but they should never replace confirmation from a pharmacist. Lighting, photo quality, packaging changes, and counterfeit products can all make “I saw a picture online” a shaky identification strategy.

If a tablet looks different from expected, the safest move is simple: do not guess. Ask the pharmacist before taking it. Pharmacists are basically medication detectives with better lighting and fewer trench coats.

Common Side Effects of Veozah

Like all medications, Veozah can cause side effects. Common side effects reported in labeling include:

• Abdominal pain
• Diarrhea
• Insomnia or trouble sleeping
• Back pain
• Hot flashes or hot flushes
• Elevated liver transaminases, which are liver enzyme blood test changes

The mention of hot flashes as a side effect can sound odd because Veozah is used to reduce hot flashes. It does not mean the medication is pointless. It means some people in clinical studies still reported hot flashes during treatment. Veozah may reduce frequency and severity, but it is not a magic wand with a prescription label.

Any side effect that is severe, persistent, or worrying should be discussed with a healthcare professional. Side effects can be mild in one person and disruptive in another. Bodies are not copy-and-paste documents.

Serious Warning: Liver Injury Risk

The most important safety issue with Veozah is liver injury. The FDA added a boxed warning to highlight rare but serious liver injury associated with Veozah. This warning does not mean every patient will have liver problems, but it does mean monitoring is not optional background noise.

Patients are advised to stop Veozah immediately and seek medical attention, including liver laboratory tests, if signs or symptoms of liver injury appear. Warning symptoms may include unusual fatigue, decreased appetite, nausea, vomiting, itching, yellowing of the skin or eyes, pale stools, dark urine, or abdominal pain.

Those symptoms may sound broad, and that is exactly why they should not be ignored. Liver problems do not always arrive wearing a name tag. A person may just feel unusually unwell at first. When a medication carries a liver warning, vague symptoms deserve serious attention.

Who Should Not Use Veozah?

Veozah is contraindicated for people with certain conditions or medication combinations. According to current labeling, it should not be used in patients with known cirrhosis, severe renal impairment, end-stage renal disease, or concomitant use of CYP1A2 inhibitors.

Before prescribing Veozah, healthcare professionals need to review liver history, kidney function, current medications, over-the-counter products, vitamins, and herbal supplements. This medication review is not small talk. It is how clinicians catch interactions before they become problems.

Veozah Drug Interactions

Veozah is affected by CYP1A2, an enzyme involved in drug metabolism. CYP1A2 inhibitors can increase fezolinetant exposure in the body, which may raise the risk of side effects. Current labeling states that Veozah is contraindicated with CYP1A2 inhibitors.

Examples studied in labeling include fluvoxamine as a strong CYP1A2 inhibitor, mexiletine as a moderate inhibitor, and cimetidine as a weak inhibitor. This does not mean those are the only medicines that matter. The practical takeaway is that every medication list should be checked by a prescriber or pharmacist before Veozah is started and whenever something new is added.

Patients should also mention supplements and nonprescription products. “Natural” products can still affect drug metabolism. Poison ivy is natural too, and nobody invites it to brunch.

Veozah and Pregnancy or Breastfeeding

Veozah is intended for vasomotor symptoms due to menopause. Current patient information advises patients to tell their healthcare provider if they are pregnant, plan to become pregnant, or are breastfeeding. There are no adequate human data to establish safety in pregnancy. While pregnancy is less likely after menopause, perimenopause can be unpredictable, and assumptions are not a reliable birth control method.

How Well Does Veozah Work?

FDA trial information shows Veozah was studied in postmenopausal participants who had frequent moderate to severe vasomotor symptoms. In two key trials, Veozah 45 mg showed statistically significant reductions from baseline in frequency and severity of moderate to severe vasomotor symptoms compared with placebo at weeks four and twelve.

That does not mean every person gets the same result. Some may notice meaningful improvement, while others may see less benefit or stop because of side effects, lab changes, cost, or preference. Real treatment decisions often involve balancing symptom relief, safety monitoring, other medical conditions, insurance coverage, and personal comfort with the plan.

Veozah vs. Hormone Therapy

Veozah is not hormone therapy, and it does not treat every menopause-related issue. Hormone therapy may help multiple menopause symptoms for appropriate candidates, including hot flashes and genitourinary symptoms. Veozah is focused on vasomotor symptoms. That makes it useful for a specific lane, not the entire menopause highway.

For people who cannot or do not want to use hormones, Veozah may be part of a discussion with a clinician. Other nonhormonal options may include certain antidepressants, gabapentin, clonidine, lifestyle strategies, and newer prescription options depending on availability and individual health factors. The best choice is not always the newest choice. It is the one that fits the person safely.

Questions to Ask a Healthcare Provider

Anyone considering Veozah may want to ask practical questions before starting. For example: Are my hot flashes definitely related to menopause? Do I need baseline liver tests? How often will labs be scheduled? Do any of my current medicines interact with Veozah? What symptoms should make me stop the medication and call right away? How will we decide whether it is working?

These questions are not “being difficult.” They are smart. A good medication plan should include the “why,” the “how,” and the “what if.”

Experience Notes: What the Veozah Journey May Feel Like in Real Life

For many people, the most relatable part of Veozah is not the receptor science; it is the daily reality of trying to sleep without waking up drenched, irritated, and bargaining with the ceiling fan. A typical patient experience may begin after months, or even years, of hot flashes that seem to run on their own schedule. One person may describe it as a sudden wave of heat from chest to face. Another may say night sweats are the real villain because they turn sleep into a series of costume changes.

When Veozah comes up in a medical visit, the conversation usually starts with goals. Is the patient trying to sleep through the night? Reduce daytime hot flashes? Avoid hormone therapy? Manage symptoms after being told estrogen is not a good fit? These goals matter because “better” can mean different things. For one person, fewer hot flashes during work is a victory. For another, sleeping four uninterrupted hours feels like winning an Olympic medal in pajamas.

The next part of the experience is less glamorous but important: lab work. Some patients may feel annoyed by the liver testing schedule, especially if they already have a busy life. But the testing is there for a reason. Veozah’s liver warning means treatment is not just about symptom relief; it is also about watching for safety signals. A practical approach is to schedule lab appointments early, set calendar reminders, and keep a simple symptom log. The log does not need to be fancy. A few notes about hot flash frequency, night sweats, sleep quality, side effects, and unusual symptoms can make follow-up visits more useful.

Some people may hope Veozah works overnight. It is understandable. When hot flashes are ruining sleep, patience has the charm of a wet sock. Still, clinical improvement is usually evaluated over weeks, not hours. A prescriber may look at how symptoms change after several weeks and whether any side effects or lab results raise concerns. If the medication helps, the benefit may feel surprisingly practical: fewer clothing changes, less dread before presentations, better sleep, or fewer moments of standing in front of the freezer pretending to inspect frozen peas.

Cost and access can also shape the real-world experience. As a newer branded medication, Veozah may be expensive depending on insurance coverage. Some patients may need prior authorization, coupons, or alternative treatment discussions. That process can be frustrating, but it is common with newer prescriptions. The best strategy is to involve the prescriber’s office and pharmacist early so delays do not turn into a paperwork scavenger hunt.

The most important experience-based reminder is this: Veozah is not a casual supplement and should not be shared with anyone else. Even if two people have similar hot flashes, they may have very different liver health, kidney function, medication lists, and risks. Prescription medicines are personalized for a reason. The right experience with Veozah is not just “Did it reduce hot flashes?” It is “Did it reduce symptoms safely, with proper monitoring, for the right patient?”

Conclusion

Veozah (fezolinetant) is an important nonhormonal option for adults with moderate to severe vasomotor symptoms due to menopause. It works by targeting NK3 receptor signaling involved in temperature regulation, offering an alternative for people who may not want or may not be able to use hormone therapy.

Its benefits must be weighed with its risks. The liver warning is the star of the safety section, and it deserves the spotlight. Baseline and follow-up liver blood tests are part of responsible treatment. Patients should know the warning symptoms of liver injury, review all medications for CYP1A2 interactions, and use Veozah only under medical supervision.

In short, Veozah may help turn down the heat, but it should be used with a clear plan, lab monitoring, and a healthcare professional who knows the patient’s full medical picture.